Article: Peanut allergy vaccine may be close to testing in humans

An experimental vaccine against peanut allergies that protected mice from deadly reactions could begin human clinical tests in a year or two, according to a report in the Journal of Allergy and Clinical Immunology.

The vaccine was made from bacteria genetically engineered to produce modified peanut proteins, then killed with heat treatment. Given in suppository form, the three-dose vaccine turned off allergic reactions in mice, which remained protected from a peanut challenge three months later. Humans might need annual boosters, said Dr. Hugh Sampson of Mount Sinai Medical School, who reported the advance with colleagues in New York and at Arkansas Children's Hospital in Little Rock.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!